Data / Form D filings / Orbit Genomics, Inc.
Orbit Genomics, Inc.: Form D filings
Orbit Genomics, Inc., a biotechnology company in Boulder, CO, filed 2 Form D notices with the SEC in 2025. The latest, on July 28, 2025, reports $780,000 sold of a $2 million offering to 15 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4665 NAUTILUS CT S, STE 300, Boulder, CO, 80301
- Phone
- (720) 515-0395
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2058369
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 28, 2025 | Amendment | $2,000,000 | $780,000 | $1,220,000 | 15 | Jul 29, 2024 | sec.gov |
| Mar 18, 2025 | New notice | $2,000,000 | $530,000 | $1,470,000 | 11 | Jul 29, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Oerum N Mikael | Director | |
| Harold (Skip) N Garner | Executive Officer, Director | |
| Elizabeth (Dede) N Willis | Executive Officer, Director | |
| Julie N Silber | Director |
Other biotechnology companies in Colorado that filed recently
- GelSana Therapeutics, Inc. $4.4 million · Oct 8, 2026
- Renovare Therapeutics, Inc. $100,000 · Oct 2, 2026
- EnteroTrack, LLC $2 million · Sep 25, 2026
- Shiverbright Technologies, Inc. $200,000 · Aug 7, 2026
Every Form D from the week of Jul 28, 2025 · All recent filings in Colorado · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Orbit Genomics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.